NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Vaccine Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Lymphoma Vaccine



Novel diffuse large B-cell lymphoma cancer testis antigen identified



September 8th, 2004

Scientists have identified a novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein.

According to published research from England, "Here we report that the OX-TES-1 SEREX antigen, which showed immunological reactivity with serum from 4 out of 10 diffuse large B-cell lymphoma (DLBCL) patients, is encoded by a novel gene, PAS domain containing 1 (PASD1). PASD1_v1 cDNA encodes a 639 amino-acid (aa) protein product, while an alternatively spliced variant (PASD1_v2), lacking intron 14, encodes a 773-aa protein, the first 638 aa of which are common to both proteins. The PASD1-predicted protein contains a PAS domain that, together...


Source: Vaccine Weekly (2004-09-08)

NewsRx Passes
Advertisement
More Articles

------------------------
Security by Verisign PR Login